09:14 AM EDT, 06/24/2025 (MT Newswires) -- Health care stocks were edging higher premarket Tuesday with the iShares Biotechnology ETF (IBB) advancing by 0.8% and the Health Care Select Sector SPDR Fund ( XLV ) recently up 0.6%.

Nektar Therapeutics ( NKTR ) shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.

Amarin ( AMRN ) shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.

Nuvation Bio ( NUVB ) shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.